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Background: Hypoxia target genes may serve as markers to track the response of ischemic myocardium to cell-based therapy. We used rt-PCR 
to confirm the differential expression of VEGF and three novel hypoxia target genes in hypoxia treated mesenchymal stromal cells (MSCs) and in 
ischemic myocardium treated with autologous MSCs after microarray.
Methods: Porcine marrow derived MSCs from 15 animals were cultured in hypoxic conditions for 6, 24 and 48 hours (Hy). Then the MSCs kept in 
hypoxia for 24 and 48 hrs were re-oxygenated (Hy-R) for 6, 24 and 48hr. At each time points, the MSCs cultured in normoxic conditions were used 
as control (N). Of the 23 animals with chronic myocardial ischemia (established by placement of Ameroids constrictor around the LCX), 18 animals 
received the autologous MSCs treatment, 7 animals received saline injections as control. Samples from the ischemic area were harvested 6 wks 
after treatment.
Results: In vitro studies: In Hy group, VEGFA and FXYD6 expression levels were elevated over 2-fold, at all time points (p < 0.05) compared to 
controls. FABP3, a fatty acid transport factor, was significantly up-regulated at 24 and 48hrs. However, the differential expression levels of VEGFA, 
FABP3 and FXYD6 were rapidly reduced at 6hr after re-oxygenation to the similar levels as in controls at the 24 and 48hr. CXCL12 expression level 
was persistently low in all Hy and Hy-R groups, compared to corresponding N groups. In vivo studies: VEGF was up-regulated in the ischemic areas for 
both cell or saline treated groups. CXCL12 was equally down-regulated for both groups. FABP3 was down-regulated in cell-treated samples but up-
regulated in the saline group, whereas, FXYD6 was up-regulated after MSC injections and down-regulated in saline group.
Conclusions Our in vitro quantitative rtPCR results are consistent with microarray data suggesting that FABP3 and FXYD6 are hypoxia sensitive 
targets, while CXCL12 is not. Significant changes were found in VEGF, FABP3 and FXYD6 regulations in response to hypoxia or ischemia. Therefore, 
these genetic pathways may play important roles after cell-based treatment for myocardial ischemia.
